Cargando…
Genotype Distribution and Characteristics of Chronic Hepatitis C Infection in Estonia, Latvia, Lithuania, and Ukraine: The RESPOND-C Study
Background and objectives: Since 2013, highly effective direct-acting antiviral (DAA) treatment for chronic hepatitis C (CHC) has become available, with cure rates exceeding 95%. For the choice of optimal CHC treatment, an assessment of the hepatitis C virus (HCV) genotype (GT) and liver fibrosis st...
Autores principales: | Jančorienė, Ligita, Rozentāle, Baiba, Tolmane, Ieva, Jēruma, Agita, Salupere, Riina, Buivydienė, Arida, Valantinas, Jonas, Kupčinskas, Limas, Šumskienė, Jolanta, Čiupkevičienė, Eglė, Ambrozaitis, Arvydas, Golubovska, Olga, Moroz, Larysa, Flisiak, Robert, Bondar, Borys |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534763/ https://www.ncbi.nlm.nih.gov/pubmed/37763696 http://dx.doi.org/10.3390/medicina59091577 |
Ejemplares similares
-
1235. Anti-HCV Prevalence and Associated Risk Factors in Patients of Psychiatry Hospitals in Latvia
por: Tolmane, Ieva, et al.
Publicado: (2022) -
Interleukin 28B Gene Polymorphism and Association with Chronic Hepatitis C Therapy Results in Latvia
por: Tolmane, Ieva, et al.
Publicado: (2012) -
Influenza A(H1N1)pdm09 and postpandemic influenza in Lithuania
por: Ambrozaitis, Arvydas, et al.
Publicado: (2016) -
Hepatitis C Virus Epidemiology in Lithuania: Situation before Introduction of the National Screening Programme
por: Ciupkeviciene, Egle, et al.
Publicado: (2022) -
Prevalence, incidence and residual risk of transfusion transmitted viruses (HBV, HCV and HIV infections) in Lithuanian blood donors from 2004 to 2018: The incidence/window-period model study
por: Grubyte, Samanta, et al.
Publicado: (2021)